Marcos Freitas Cordeiro

Dr. Marcos Freitas Cordeiro

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 March 2016 in Nanotechnology
Verified
Journal Article
Closed access
PDF file
AGA R Galho
A R Galho
MCMarcos Freitas Cordeiro
Marcos Freitas Cordeiro
SRS A Ribeiro
S A Ribeiro
MMM S Marques
M S Marques
MAM F D Antunes
M F D Antunes
AHA P Horn
A P Horn
Intracerebral haemorrhage (ICH) is a worldwide public health problem. Experimental studies have shown that oxidative stress plays an important role in the pathogenesis of ICH and could represent a target for its treatment. However, the blood–brain barrier is an obstacle to be overcome, as it hampers the administration of compounds to the central nervous system. In this study, we compared the effects of a quercetin-loaded nanoemulsion (QU-N) with the free form of the drug (QU-SP) in a collagenase-induced ICH rat model. Quercetin (QU) is a polyphenol that has an antioxidant effect in vitro , but due to its high lipophilicity, it has low bioavailability in vivo . In this study, animals submitted or not to ICH were treated with a single intraperitoneal QU dose (free or nanoemulsion) of 30 mg kg −1 . Motor assessment was evaluated by the open field, foot fault and beam walking behavioural tests. 72 h after surgery the haematoma size was evaluated and biochemical measurements were performed. Animals treated with QU-N had a significant improvement in the beam walking and open field tests. Also, QU-N was able to reduce the size of the haematoma, preserving the activity of glutathione S -transferase (GST), increasing GSH content, and the total antioxidant capacity. QU-SP recovered locomotor activity and increased the GSH content and the total antioxidant capacity. Thus, it can be observed that QU presented antioxidant activity in both formulations, but the incorporation into nanoemulsions increased its antioxidant effect, which was reflected in the improvement of the motor skills and in the haematoma size decrement. These results suggest that the nanoemulsion containing QU developed in this study could be promising for future studies on treatments for ICH.

1 November 2020 in Brain Research
Verified
Journal Article
Closed access
MMMagno Marques
Magno Marques
MCMarcos Freitas Cordeiro
Marcos Freitas Cordeiro
MMM.A.G. Marinho
M.A.G. Marinho
CVC.O. Vian
C.O. Vian
GVG.R. Vaz
G.R. Vaz
AHA.P. Horn
A.P. Horn

1 July 2018 in Behavioural Brain Research
Verified
Journal Article
Closed access
SFSara S. Fernandes
Sara S. Fernandes
AKAndré P. Koth
André P. Koth
GPGustavo M. Parfitt
Gustavo M. Parfitt
MCMarcos Freitas Cordeiro
Marcos Freitas Cordeiro
CPCarolina S. Peixoto
Carolina S. Peixoto
DBDaniela M. Barros
Daniela M. Barros

1 January 2018 in Toxicology and Applied Pharmacology
Verified
Journal Article
Closed access
ÂKÂndrea Barbosa Kraemer
Ândrea Barbosa Kraemer
GPGustavo Morrone Parfitt
Gustavo Morrone Parfitt
DADaiane da Silva Acosta
Daiane da Silva Acosta
GBGisele Eva Bruch
Gisele Eva Bruch
MCMarcos Freitas Cordeiro
Marcos Freitas Cordeiro
DBDaniela Martí Barros
Daniela Martí Barros

1 May 2018 in Toxicology and Applied Pharmacology
Verified
Journal Article
Closed access
MCMarcos Freitas Cordeiro
Marcos Freitas Cordeiro
FGFelipe A. Girardi
Felipe A. Girardi
CGCarla O.F. Gonçalves
Carla O.F. Gonçalves
CPCarolina S. Peixoto
Carolina S. Peixoto
LBLidiane Dal Bosco
Lidiane Dal Bosco
DBDaniela M. Barros
Daniela M. Barros

1 January 2015 in World Journal of Stem Cells
Verified
Journal Article
Open access
MCMarcos Freitas Cordeiro
Marcos Freitas Cordeiro
Intracerebral hemorrhage (ICH) is a very complex pathology, with many different not fully elucidated etiologies and prognostics. It is the most severe subtype of stroke, with high mortality and morbidity rates. Unfortunately, despite the numerous promising preclinical assays including neuroprotective, anti-hypertensive, and anti-inflammatory drugs, to this moment only symptomatic treatments are available, motivating the search for new alternatives. In this context, stem cell therapy emerged as a promising tool. However, more than a decade has passed, and there is still much to be learned not only about stem cells, but also about ICH itself, and how these two pieces come together. To date, rats have been the most widely used animal model in this research field, and there is much more to be learned from and about them. In this review, we first summarize ICH epidemiology, risk factors, and pathophysiology. We then present different methods utilized to induce ICH in rats, and examine how accurately they represent the human disease. Next, we discuss the different types of stem cells used in previous ICH studies, also taking into account the tested transplantation sites. Finally, we summarize what has been achieved in assays with stem cells in rat models of ICH, and point out some relevant issues where attention must be given in future efforts.